We're off to the races!

Novo Nordisk Launches Novoeight® for People with Hemophilia A

Novo Nordisk announced on March 26, 2015, that they willl launch Novoeight® (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A. Novoeight® offers purity, reliability, and enhanced portability, with the highest storage temperature for the longest period of time compared with other marketed recombinant Factor VIII products-up to 86°F for 12 […]